A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen (TWO2) Therapy in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study
Author(s) -
Robert G. Frykberg,
Peter Franks,
Michael Edmonds,
Jonathan N. Brantley,
Luc Téot,
Thomas Wild,
Matthew G. Garoufalis,
Aliza M. Lee,
Janette A. Thompson,
Gérard Reach,
Cyaandi Dove,
Karim Lachgar,
D. Grotemeyer,
Sophie Renton
Publication year - 2020
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc19-0476
Subject(s) - medicine , diabetic foot , placebo , diabetes mellitus , hazard ratio , randomized controlled trial , surgery , clinical endpoint , odds ratio , confidence interval , alternative medicine , pathology , endocrinology
Topical oxygen has been used for the treatment of chronic wounds for more than 50 years. Its effectiveness remains disputed due to the limited number of robust high-quality investigations. The aim of this study was to assess the efficacy of multimodality cyclical pressure Topical Wound Oxygen (TWO2) home care therapy in healing refractory diabetic foot ulcers (DFUs) that had failed to heal with standard of care (SOC) alone.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom